Skip to main content

Table 1 Baseline characteristics of COPD patients and smokers without COPD included in the study

From: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort

Variable

COPD cases

(N = 121)

Smokers

(N = 121)

p-value

Sex (male%)

66

62

N.S.

Age (years)a

57 ± 8

57 ± 8

N.S.

BMI (Kg/m2)a

27 ± 5

28 ± 4

N.S.

Smoking habitc

(pack-yrs)ac

60 ± 25

44 ± 22

<0.0001

Active smoking (%)

50

64

0.027

T/S ratioa

0.68 ± 0.25

0.88 ± 0.52

<0.0001

FEV1 (L)a

1.66 ± 0.7

2.9 ± 0.7

<0.0001

FEV1 (% pred)a

59 ± 21

101 ± 14

<0.0001

FVC (% pred)a

89 ± 22

108 ± 15

<0.0001

FEV1 / FVC (%)a

53 ± 12

76 ± 5

<0.0001

PaO2 (mmHg)a

72.3 ± 14.3

78.7 ± 10

<0.001

KCO (%)

79.6 ± 25.1

97.3 ± 21.3

0.001

IC/TLC (%)

36 ± 9

45 ± 8

<0.001

6MWD (m)a

523 ± 89

551 ± 76

0.03

mMRC dyspneab

1 (0–2)

0 (0–0)

0.006

BODE indexb

1 (0–3)

0 (0–1)

<0.001

Charlson indexb

0 (0–1)

0 (0–0)

N.S.

  1. Data are presented as amean ± SD and bmedian (25th-75thpc) and compared by Student’s t-test or Chi2 test. cNumber of packs of cigarettes smoked per day x number of years smoking. Percentage BMI body mass index, T/S ratio relative telomere length, FEV 1 forced expiratory volume in one second, FVC forced vital capacity, % pred per cent predicted. PaO 2 partial oxygen tension, K CO diffusion capacity of carbon monoxide, IC/TLC inspiratory to total lung capacity ratio, 6MWD six-min walk distance test. N.S non-significant